| Name | Title | Contact Details |
|---|
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Scale your team with high-quality, vetted professionals. 🚀 MSH is a global technology and talent solutions provider that empowers people and the places they work to thrive. The companys leading-edge services and support provide organizations with the business intelligence and high-quality, vetted candidates they need to succeed at a speed and scale others cannot in 35+ markets across three continents. By engaging MSHs human-centered and collaborative platform, hiring leaders and talent professionals are empowered to find the highest quality candidates, while putting the candidate experience front and center. Founded in 2011 and headquartered in Fort Lauderdale, Fla., MSH is certified as a Minority Business Enterprise by the National Minority Supplier Development Council.
Founded by Josh Harris and David Blitzer, with a significant strategic investment by The Chernin Group (TCG), Unrivaled Sports oversees a diverse portfolio of youth sports properties across Baseball, Softball, Football, and Action Sports. Unrivaled Sports portfolio includes Ripken Baseball®, Cooperstown All Star Village, Sports Force Parks™, Baseball Factory™, Softball Factory™, We Are Camp, and the ForeverLawn Sports Complex at the Pro Football Hall of Fame Village. Unrivaled Sports has partnerships in Baseball with Hall of Famer Cal Ripken, Jr., and in Action Sports with 5-time Olympian Shaun White. All its properties are committed to providing young athletes with world-class experiences, development opportunities, and platforms to excel. Learn more at playunrivaled.com.
Model No. was founded to rethink and elevate our experience in the spaces we design and inhabit. We design and make furnishings that harmonize with the space, lift the human experience, and eliminate our impact on the environment. Our collaborators - architects and design professionals - see the problem: Building and the turnover of commercial interiors generate well-over a third of the worlds CO2 emissions and an endless stream of waste. With these mission-driven partners, we create spaces we want without the waste. Circular at our core, Model No. achieves this through elevated design, regenerative and biodegradable materials, and 3D manufacturing. Starting a project with us begins with an email: info@model-no.com